Stockchase Opinions

Jim Cramer - Mad Money Chewy, Inc. CHWY-N BUY Dec 12, 2022

This online pet food store sold off last week and that was a mistake. Even after Covid, pets are highly desirable. This stock peaked during Covid (after the company went public in mid-2019) and got a boost from the meme stock traders. It bottomed above $20 last May, but has rebounded 103% since at one point. Their active customer base roughly doubled before and during Covid and sales exploded. In 2021, 70% of its sales automatically renewed, so there's hope that Chewy can endure after Covid. But the stock became overvalued last year and the market turned against pandemic plays. He likes it now, because they have pivoted to profitability. At early June they reported a better than expected quarter and a profit (expectations were very low though). Last Thursday's report beat the number of active customers and sales (up 14.5% YOY) and raised their full-year margin forecast. Chewy isn't cheap, but if they keep putting up great numbers, then this is a winner.
N/A

Stock price when the opinion was issued

Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY
People bought pets during the pandemic and they need to continue to feed those pets. With more pet owners, sales and revenues for CHWY will keep increasing. He continues to be long this.
BUY
They just reported. He's long Chewy. People won't stop feeding their pets post-Covid. Chewy will break above $100 again, sooner than later.
DON'T BUY

They need to make profits. They don't make money.

DON'T BUY

Is astonished these shares have fallen so far, because so many use their products, but the entire pet sector is in the doghouse.

BUY

It's a comeback story after sliding post-Covid. Shares jumped 27% this week after reporting. They introduced pet care clinics that helps bring down pet care costs. They execute well. Gross margins have expanded. They announced a $500 million buyback and are succeeding in the face of Amazon.

premium

It's a Monthly Gems opinion which is available only for Premium members

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK

Once a dog, this American pet food maker is a comeback after reporting Q1 results. Shares jumped 30% after the company reported earnings per share (EPS) of US$0.15, which blew away street estimates by 291%. Meanwhile, revenues of US$2.9 billion (all USD)were in line. Net income more than tripled from a year ago to $67.3 million, or $0.15 per share while gross margins climbed 130 basis points to 29.7% and net margins increased 150 basis points to 2.3%. Growth has moderated, but profits are now consistent and growing. Analysts were impressed enough to raise Chewy's price target rose by 8.4% to US$25.12. So, how did the company beat the post-Covid slump? One step was recently opening Chewy Vet Care clinics, targeting younger, tech-savvy pet owners, who can see their pet's medical information displayed on interactive screens in the exam room but also access that data on their portable devices. This cohort of Millennials and GenZ'ers make up 46% of pet owners in the U.S., so penetrating this market through the clinics is a savvy move.

BUY ON WEAKNESS

They reported last week a nice revenue and adjusted EBITDA beat, and raised their full-year forecast. And yet, shares plunged 7%, because shares came into the report hot, up 23% in November. CHWY forecast Q4 margins at 3-3.8%, while the street expected 3.9% and was disappointed. Buy on this dip because of strong numbers: 20.2 million active members, more than expected, and $567.50 spending per active customer, a record high, and pet adoption in the industry growing around 10%, a positive sign. Also, their six vet clinics are bringing in new customers, and they plan to open two more. Also, the clinics are expanding to Canada (Toronto).

BUY

 It reports Wednesday. Their last 2 quarters have been strong.